Quality of RCTs exploring Helicobacter pylori eradication for the prevention of gastric cancer and preneoplastic lesions

被引:0
|
作者
Sun, Tian-Tian [1 ]
Wang, Ji-Lin [1 ]
Fang, Jing-Yuan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Shanghai Inst Digest Dis, Shanghai 200001, Peoples R China
关键词
gastric cancer; Helicobacter pylori eradication; methodological quality; preneoplastic lesion; reporting quality; INTESTINAL METAPLASIA; RANDOMIZED-TRIALS; ATROPHIC GASTRITIS; CONSORT STATEMENT; DOUBLE-BLIND; INFECTION; THERAPY; CURE; CARCINOGENESIS; PROGRESSION;
D O I
10.1586/ERA.11.124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Randomized controlled trials (RCTs) are considered the gold standard for evaluating the efficacy of clinical interventions and developing evidence-based clinical practice guidelines; however, they can yield biased results when their methodology is less than rigorous, or their published reports fail to report key items. A number of RCTs have been carried out to explore the relationship between Helicobacter pylori eradication and gastric cancer, but their results remain controversial. In this article, we will comprehensively review searched medical electronic databases, and appraise the reporting and methodological quality of these relevant RCTs according to the Consolidated Standards of Reporting Trials 2010 statement and the Cochrane Handbook in order to learn about the internal and external validity of these RCTs.
引用
收藏
页码:1509 / 1519
页数:11
相关论文
共 50 条
  • [21] Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges
    Liu, Zongchao
    Xu, Hengmin
    You, Weicheng
    Pan, Kaifeng
    Li, Wenqing
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (04): : 299 - 310
  • [22] Prevention of gastric cancer by Helicobacter pylori eradication?: Results from clinical intervention studies
    Schandl, L
    Malfertheiner, P
    Ebert, MPA
    DIGESTIVE DISEASES, 2002, 20 (01) : 18 - 22
  • [23] Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention
    Corral, Juan E.
    Mera, Robertino
    Dye, Corey W.
    Morgan, Douglas R.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (04) : 184 - 193
  • [24] Can gastric cancer be prevented by Helicobacter pylori eradication?
    Malfertheiner, Peter
    Fry, Lucia C.
    Moenkemueller, Klaus
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (04) : 709 - 719
  • [25] Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai)
    Du, Yiqi
    Zhu, Huiyun
    Liu, Jiong
    Li, Jingnan
    Chang, Xin
    Zhou, Liya
    Chen, Minhu
    Lu, Nonghua
    Li, Zhaoshen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (04) : 624 - 629
  • [26] Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism
    Kim, Nayoung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (08) : 1287 - 1295
  • [27] Pathogenesis and risk factors for gastric cancer after Helicobacter pylori eradication
    Ohba, Reina
    Iijima, Katsunori
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 8 (09) : 663 - 672
  • [28] Mass screening and eradication of Helicobacter pylori as the policy recommendations for gastric cancer prevention
    Chiang, Tsung-Hsien
    Cheng, Hsiu-Chi
    Chuang, Shu-Lin
    Chen, Yi-Ru
    Hsu, Yu-Hsin
    Hsu, Tsui-Hsia
    Lin, Li-Ju
    Lin, Yu-Wen
    Chu, Chia-Hsiang
    Wu, Ming-Shiang
    Lee, Yi-Chia
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (12) : 2378 - 2392
  • [29] Helicobacter pylori eradication for the prevention of gastric neoplasia
    Ford, Alexander C.
    Forman, David
    Hunt, Richard
    Yuan, Yuhong
    Moayyedi, Paul
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (07):
  • [30] The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal
    Wu, Jeng-Yih
    Lee, Yi-Chia
    Graham, David Y.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (01) : 17 - 24